Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 ...

Retrieved on: 2023-10-17 17:12:21

Tags for this article:

Oncogenes

Lung cancer

Tyrosine kinase receptors

Myc

Epidermal growth factor receptor

Non-small-cell lung cancer

Omega Therapeutics Inc.

Click the tags to see associated articles and topics

Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 .... View article details on HISWAI: https://www.biospace.com/article/releases/omega-therapeutics-presents-new-preclinical-data-supporting-the-potential-of-otx-2101-in-combination-settings-for-treatment-of-nsclc/

Excerpt

(Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA ...

Article found on: www.biospace.com

View Original Article